{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:17:42Z","timestamp":1786119462334,"version":"build-2736575974"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1097\/spc.0b013e32833929aa","type":"journal-article","created":{"date-parts":[[2010,4,27]],"date-time":"2010-04-27T13:09:32Z","timestamp":1272373772000},"page":"63-68","source":"Crossref","is-referenced-by-count":19,"title":["The management of dyspnoea in chronic heart failure"],"prefix":"10.1097","volume":"4","author":[{"given":"Miriam J","family":"Johnson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen G","family":"Oxberry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-4-20211004","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/SPC.0b013e3282ff122e","article-title":"Review of the evidence for the management of dyspnoea in people with chronic heart failure","volume":"2","author":"Oxberry","year":"2008","journal-title":"Curr Opin Support Palliat Care"},{"key":"R2-4-20211004","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1093\/eurheartj\/ehn048","article-title":"A proposal to standardize dyspnoea measurement in clinical trials of acute heart failure syndromes: the need for a uniform approach","volume":"29","author":"Pang","year":"2008","journal-title":"Eur Heart J"},{"key":"R3-4-20211004","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.rmed.2006.07.003","article-title":"Measurement of breathlessness in advanced disease: a systematic review","volume":"101","author":"Bausewein","year":"2007","journal-title":"Respir Med"},{"key":"R4-4-20211004","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1177\/0269216307076398","article-title":"Which measurement scales should we use to measure breathlessness in palliative care? A systematic review","volume":"21","author":"Dorman","year":"2007","journal-title":"Palliat Med"},{"key":"R5-4-20211004","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1177\/0269216309102520","article-title":"Researching breathlessness in palliative care: consensus statement of the National Cancer Research Institute Palliative Care Breathlessness Subgroup","volume":"23","author":"Dorman","year":"2009","journal-title":"Palliat Med"},{"key":"R6-4-20211004","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.cardfail.2005.03.007","article-title":"Symptoms in patients with heart failure are prognostic predictors: insights from COMET","volume":"11","author":"Ekman","year":"2005","journal-title":"J Card Fail"},{"key":"R7-4-20211004","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/eurjhf\/hfp194","article-title":"Measurement of breathlessness in clinical trials in patients with chronic heart failure: the need for a standardised approach. A systematic review","volume":"12","author":"Johnson","year":"2010","journal-title":"Eur J Heart Fail"},{"key":"R9-4-20211004","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1001\/jama.2009.457","article-title":"Effects of exercise training on health status in patients with chronic heart failure: HF-ACTION randomized controlled trial","volume":"301","author":"Flynn","year":"2009","journal-title":"JAMA"},{"key":"R10-4-20211004","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ejcnurse.2007.08.002","article-title":"The effects of exercise training on fatigue and dyspnea in heart failure","volume":"7","author":"Pozehl","year":"2008","journal-title":"Eur J Cardiovasc Nurs"},{"key":"R11-4-20211004","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ahj.2008.08.033","article-title":"The Support, Education, and Research in Chronic Heart Failure Study (SEARCH): a mindfulness-based psychoeducational intervention improves depression and clinical symptoms in patients with chronic heart failure","volume":"157","author":"Sullivan","year":"2009","journal-title":"Am Heart J"},{"key":"R12-4-20211004","doi-asserted-by":"crossref","first-page":"861","DOI":"10.2165\/00002018-200730100-00005","article-title":"Corticosteroid-induced adverse events in adults: frequency, screening and prevention","volume":"30","author":"Fardet","year":"2007","journal-title":"Drug Saf"},{"key":"R13-4-20211004","doi-asserted-by":"crossref","first-page":"567","DOI":"10.2165\/00002018-200629070-00003","article-title":"Heart failure induced by noncardiac drugs","volume":"29","author":"Slordal","year":"2006","journal-title":"Drug Saf"},{"key":"R14-4-20211004","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1530\/EJE-07-0455","article-title":"Glucocorticoids and cardiovascular disease","volume":"157","author":"Walker","year":"2007","journal-title":"Eur J Endocrinol"},{"key":"R15-4-20211004","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1536\/ihj.49.587","article-title":"Prednisone adding to usual care treatment for refractory decompensated congestive heart failure","volume":"49","author":"Zhang","year":"2008","journal-title":"Int Heart J"},{"key":"R16-4-20211004","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1136\/hrt.78.5.429","article-title":"The origin of symptoms in chronic heart failure","volume":"78","author":"Clark","year":"1997","journal-title":"Heart"},{"key":"R17-4-20211004","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.2174\/092986707781389619","article-title":"The role of PDE5-inhibitors in cardiopulmonary disorders: from basic evidence to clinical development","volume":"14","author":"Guazzi","year":"2007","journal-title":"Curr Med Chem"},{"key":"R18-4-20211004","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1016\/j.jacc.2007.07.078","article-title":"Long-term use of sildenafil in the therapeutic management of heart failure","volume":"50","author":"Guazzi","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"R20-4-20211004","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.annemergmed.2007.04.005","article-title":"Bronchodilator therapy in acute decompensated heart failure patients without a history of chronic obstructive pulmonary disease","volume":"51","author":"Singer","year":"2008","journal-title":"Ann Emerg Med"},{"key":"R21-4-20211004","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1378\/chest.128.2.1050","article-title":"Expiratory flow limitation is associated with orthopnea and reversed by vasodilators and diuretics in left heart failure","volume":"128","author":"Boni","year":"2005","journal-title":"Chest"},{"key":"R22-4-20211004","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1517\/14656560802682213","article-title":"Rolofylline: a selective adenosine 1 receptor antagonist for the treatment of heart failure","volume":"10","author":"Slawsky","year":"2009","journal-title":"Expert Opin Pharmacother"},{"key":"R23-4-20211004","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.cardfail.2008.08.010","article-title":"The PROTECT pilot study: a randomized, placebo-controlled, dose-finding study of the adenosine A1 receptor antagonist rolofylline in patients with acute heart failure and renal impairment","volume":"14","author":"Cotter","year":"2008","journal-title":"J Card Fail"},{"key":"R24-4-20211004","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/j.jacc.2007.07.019","article-title":"The effects of KW-3902, an adenosine A1-receptor antagonist, on diuresis and renal function in patients with acute decompensated heart failure and renal impairment or diuretic resistance","volume":"50","author":"Givertz","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"R25-4-20211004","first-page":"1531","article-title":"Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial.","volume":"287","year":"2002","journal-title":"JAMA"},{"key":"R26-4-20211004","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.ajem.2004.11.002","article-title":"Nesiritide added to standard care favorably reduces systolic blood pressure compared with standard care alone in patients with acute decompensated heart failure","volume":"23","author":"Peacock","year":"2005","journal-title":"Am J Emerg Med"},{"key":"R27-4-20211004","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.jemermed.2006.10.001","article-title":"Initial results from the PROACTION study","volume":"31","author":"Peacock","year":"2006","journal-title":"J Emerg Med"},{"key":"R28-4-20211004","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1001\/jama.296.18.2217","article-title":"Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure","volume":"296","author":"Gheorghiade","year":"2006","journal-title":"JAMA"},{"key":"R29-4-20211004","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.annemergmed.2007.12.003","article-title":"Acutely decompensated heart failure in a country emergency department: a double-blind randomized controlled comparison of nesiritide versus placebo treatment","volume":"51","author":"Miller","year":"2008","journal-title":"Ann Emerg Med"},{"key":"R30-4-20211004","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/S0140-6736(09)60622-X","article-title":"Relaxin for the treatment of patients with acute heart failure (Pre-RELAX-AHF): a multicentre, randomised, placebo-controlled, parallel-group, dose-finding phase IIb study","volume":"373","author":"Teerlink","year":"2009","journal-title":"Lancet"},{"key":"R31-4-20211004","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1253\/circj.CJ-07-0760","article-title":"Multicenter prospective investigation on efficacy and safety of carperitide as a first-line drug for acute heart failure syndrome with preserved blood pressure: COMPASS: Carperitide Effects Observed Through Monitoring Dyspnea in Acute Decompensated Heart Failure Study","volume":"72","author":"Nomura","year":"2008","journal-title":"Circ J"},{"key":"R32-4-20211004","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.jpainsymman.2007.10.017","article-title":"Nebulized furosemide for the management of dyspnea: does the evidence support its use?","volume":"36","author":"Newton","year":"2008","journal-title":"J Pain Symptom Manage"},{"key":"R34-4-20211004","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1136\/emj.2007.050419","article-title":"Morphine and outcomes in acute decompensated heart failure: an ADHERE analysis","volume":"25","author":"Peacock","year":"2008","journal-title":"Emerg Med J"},{"key":"R35-4-20211004","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0735-1097(96)00446-9","article-title":"Effects of dihydrocodeine on chemosensitivity and exercise tolerance in patients with chronic heart failure","volume":"29","author":"Chua","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"R36-4-20211004","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1183\/09031936.00145208","article-title":"Endogenous opioids modify dyspnoea during treadmill exercise in patients with COPD","volume":"33","author":"Mahler","year":"2009","journal-title":"Eur Respir J"},{"key":"R37-4-20211004","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/MJT.0b013e31816b436e","article-title":"Design and rationale of the URGENT dyspnea study: an international, multicenter, prospective study","volume":"15","author":"Pang","year":"2008","journal-title":"Am J Ther"},{"key":"R38-4-20211004","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1176\/ajp.152.10.1531a","article-title":"Sertraline for chronic obstructive pulmonary disease and comorbid anxiety and mood disorders","volume":"152","author":"Papp","year":"1995","journal-title":"Am J Psychiatry"},{"key":"R39-4-20211004","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/da.20041","article-title":"Selective serotonin re-uptake inhibitors beyond psychiatry: are they useful in the treatment of severe, chronic, obstructive pulmonary disease?","volume":"20","author":"Perna","year":"2004","journal-title":"Depress Anxiety"},{"key":"R40-4-20211004","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S0033-3182(98)71377-5","article-title":"Sertraline effects on dyspnea in patients with obstructive airways disease","volume":"39","author":"Smoller","year":"1998","journal-title":"Psychosomatics"}],"container-title":["Current Opinion in Supportive & Palliative Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01263393-201006000-00004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:18:20Z","timestamp":1786040300000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01263393-201006000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/spc.0b013e32833929aa","relation":{},"ISSN":["1751-4258"],"issn-type":[{"value":"1751-4258","type":"print"}],"subject":[],"published":{"date-parts":[[2010,6]]}}}